Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
about
The impact of chronic conditions on the economic burden of cancer survivorship: a systematic reviewA data mining approach for grouping and analyzing trajectories of care using claim data: the example of breast cancerInventory of data sources for estimating health care costs in the United States.Spending more, doing more, or both? An alternative method for quantifying utilization during hospitalizationsMedical expenditures of adult cancer survivors aged <65 years in the United States.Cost of illness in colorectal cancer: an international review.Medical cost trajectories and onsets of cancer and noncancer diseases in US elderly population.National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008Economic burden of cancer in the United States: estimates, projections, and future researchEstimating the health and economic burden of cancer among those diagnosed as adolescents and young adultsChemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study.When does an episode of care for cancer begin?Academic-Community Partnership to Develop a Patient-Centered Breast Cancer Risk Reduction Program for Latina Primary Care PatientsCost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors.Economic burden of cancer survivorship among adults in the United StatesOverview of methods to estimate the medical costs of cancerEconomic studies in colorectal cancer: challenges in measuring and comparing costs.The financial burden of cancer care: do patients in the US know what to expect?Economic Burden of Chronic Conditions Among Survivors of Cancer in the United States.Antineoplastic Treatment of Advanced-Stage Non-Small-Cell Lung Cancer: Treatment, Survival, and Spending (2000 to 2011).The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement.Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients?Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years.Cost-of-illness models for venous thromboembolism: One size does not fit all.Costs of colorectal cancer in different states of the disease.The Economics of Breast Cancer in Younger Women in the U.S.: The Present and Future.National cost study versus hospital cost accounting for organ recovery cost assessment in a French hospital groupHealth services costs for cancer care in Australia: Estimates from the 45 and Up Study
P2860
Q30393166-1ADA9E5A-9DFE-4185-BA31-D773A253044BQ30704360-F6CDFCC4-0A46-4C11-952D-63ACD4ED3089Q33470180-C14C28ED-1798-4CEB-B162-5FED3E41BE9DQ33583749-FCF318C3-5F16-4339-8BC8-EAD6C54A8B21Q34013261-BF7DE5D9-4917-49B6-8B78-B958CF4B807CQ34699421-9A2C5FE8-B3B1-45A4-B9F9-1BE7ADDDFF61Q35046444-06C60ED9-3302-4B3D-A1FA-715D35390091Q35114551-EE1D4608-F6DB-4ACB-A81D-F735F3F69254Q35327245-94B3264A-B4D2-4ACE-BF9B-753D7FD6EF96Q36092297-4DE448E7-378C-4E87-98F5-4BCAAC72C1D0Q36240745-09166379-E1CE-4D9C-A3A4-3492E3806566Q36680933-7DA5A192-5727-491F-9C29-C8002E6330E4Q36992450-3AB6ECAC-0BCD-4D69-8DAD-81372FF9BBFCQ37157162-6E791667-CAF9-4E52-9833-678DF0AFBC68Q37227668-9AC6AAA0-4970-4233-99C7-D52258382EDCQ37286387-2A7A06FD-420D-4981-BF72-D50AC22FBD1CQ37383663-9DBE7598-4D94-42AD-BA3B-D0767DCAF34CQ38255597-4C0E4C88-447B-4C5A-B308-6593209A79D2Q38804816-C1EBC9E7-7F72-40DD-A7B4-92DA2815BC32Q39043072-F657DA9B-6B34-40BB-8A96-0A7C05F5E208Q39547177-80D6544F-647A-4143-B723-126BFB5BF708Q40073170-C87E1706-3256-4DDB-8FF8-4B28E814018FQ40098790-1F8418A7-A409-45D9-BEDB-B7A72F653A9AQ40098794-012E786C-0D47-4F04-9047-71BF87F3CD31Q41125210-CC70A2C6-D52D-4AF9-B290-1FB96D1278A2Q41676257-DC6AFD7A-9ED6-445D-9D0D-C2640BF5BB7FQ43727107-B6FEDA94-4C7F-4436-AE83-DD6B6C5B32BAQ57815846-1DD527B4-CA34-484F-B159-DF1D8E71FF2BQ58008153-48D958A0-60F2-47B3-AFB6-1464F2F5CEA9
P2860
Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparison of approaches for e ...... is the impact of data source?
@ast
Comparison of approaches for e ...... is the impact of data source?
@en
type
label
Comparison of approaches for e ...... is the impact of data source?
@ast
Comparison of approaches for e ...... is the impact of data source?
@en
prefLabel
Comparison of approaches for e ...... is the impact of data source?
@ast
Comparison of approaches for e ...... is the impact of data source?
@en
P2093
P2860
P1433
P1476
Comparison of approaches for e ...... is the impact of data source?
@en
P2093
Angela Mariotto
Angela Meekins
Deborah Schrag
Jessica Banthin
Joan L Warren
K Robin Yabroff
Marie Topor
Martin L Brown
William Lawrence
P2860
P356
10.1097/MLR.0B013E3181A23E25
P433
P577
2009-07-01T00:00:00Z